JP2009506055A - 第四級アンモニウムポリマーおよびコポリマーを用いた殺菌剤 - Google Patents
第四級アンモニウムポリマーおよびコポリマーを用いた殺菌剤 Download PDFInfo
- Publication number
- JP2009506055A JP2009506055A JP2008528125A JP2008528125A JP2009506055A JP 2009506055 A JP2009506055 A JP 2009506055A JP 2008528125 A JP2008528125 A JP 2008528125A JP 2008528125 A JP2008528125 A JP 2008528125A JP 2009506055 A JP2009506055 A JP 2009506055A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- polymer
- antimicrobial
- antibacterial
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920000642 polymer Polymers 0.000 title claims abstract description 111
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 69
- 125000001453 quaternary ammonium group Chemical group 0.000 title claims description 29
- 229920001577 copolymer Polymers 0.000 title description 7
- 239000003899 bactericide agent Substances 0.000 title description 5
- 239000000203 mixture Substances 0.000 claims abstract description 118
- 229920002118 antimicrobial polymer Polymers 0.000 claims abstract description 46
- 238000000576 coating method Methods 0.000 claims abstract description 32
- 239000011248 coating agent Substances 0.000 claims abstract description 29
- 239000002184 metal Substances 0.000 claims abstract description 14
- 229910052751 metal Inorganic materials 0.000 claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 97
- 230000000845 anti-microbial effect Effects 0.000 claims description 52
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 50
- 239000002904 solvent Substances 0.000 claims description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 39
- 239000000178 monomer Substances 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 32
- 239000000126 substance Substances 0.000 claims description 29
- 229920002635 polyurethane Polymers 0.000 claims description 23
- 239000004814 polyurethane Substances 0.000 claims description 23
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical group CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 15
- 239000004599 antimicrobial Substances 0.000 claims description 15
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical group O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims description 12
- 239000003974 emollient agent Substances 0.000 claims description 11
- 238000006116 polymerization reaction Methods 0.000 claims description 11
- 239000003242 anti bacterial agent Substances 0.000 claims description 10
- 230000000249 desinfective effect Effects 0.000 claims description 10
- 239000003755 preservative agent Substances 0.000 claims description 10
- 239000000654 additive Substances 0.000 claims description 9
- 238000002386 leaching Methods 0.000 claims description 9
- 229920002554 vinyl polymer Polymers 0.000 claims description 9
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 8
- 229940123208 Biguanide Drugs 0.000 claims description 6
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 6
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 6
- VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Polymers CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 claims description 5
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 5
- 230000000996 additive effect Effects 0.000 claims description 5
- 229960000686 benzalkonium chloride Drugs 0.000 claims description 5
- 230000006870 function Effects 0.000 claims description 5
- 150000002989 phenols Chemical class 0.000 claims description 5
- 239000000049 pigment Substances 0.000 claims description 5
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 claims description 4
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 4
- 239000006096 absorbing agent Substances 0.000 claims description 4
- 238000013508 migration Methods 0.000 claims description 4
- 230000005012 migration Effects 0.000 claims description 4
- 230000002085 persistent effect Effects 0.000 claims description 4
- 229960003500 triclosan Drugs 0.000 claims description 4
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 3
- RUPBZQFQVRMKDG-UHFFFAOYSA-M Didecyldimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC RUPBZQFQVRMKDG-UHFFFAOYSA-M 0.000 claims description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000000443 aerosol Substances 0.000 claims description 3
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 claims description 3
- 229960001950 benzethonium chloride Drugs 0.000 claims description 3
- 229960003260 chlorhexidine Drugs 0.000 claims description 3
- 238000010828 elution Methods 0.000 claims description 3
- 239000006260 foam Substances 0.000 claims description 3
- 230000007246 mechanism Effects 0.000 claims description 3
- 239000002562 thickening agent Substances 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 239000004909 Moisturizer Substances 0.000 claims description 2
- 150000004283 biguanides Chemical class 0.000 claims description 2
- 238000001704 evaporation Methods 0.000 claims description 2
- 230000001333 moisturizer Effects 0.000 claims description 2
- 230000009965 odorless effect Effects 0.000 claims description 2
- 150000001298 alcohols Chemical class 0.000 claims 1
- XIWFQDBQMCDYJT-UHFFFAOYSA-M benzyl-dimethyl-tridecylazanium;chloride Chemical group [Cl-].CCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 XIWFQDBQMCDYJT-UHFFFAOYSA-M 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 abstract description 19
- 150000001875 compounds Chemical class 0.000 abstract description 6
- 210000003491 skin Anatomy 0.000 description 74
- 239000000243 solution Substances 0.000 description 69
- 241000894006 Bacteria Species 0.000 description 53
- 238000012360 testing method Methods 0.000 description 27
- 244000005700 microbiome Species 0.000 description 25
- 239000005388 borosilicate glass Substances 0.000 description 21
- 239000011521 glass Substances 0.000 description 20
- 238000006386 neutralization reaction Methods 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 17
- 239000002054 inoculum Substances 0.000 description 17
- 239000002609 medium Substances 0.000 description 17
- 239000000758 substrate Substances 0.000 description 17
- 235000013305 food Nutrition 0.000 description 16
- 238000004659 sterilization and disinfection Methods 0.000 description 16
- 239000000975 dye Substances 0.000 description 15
- 241000233866 Fungi Species 0.000 description 14
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
- 239000006210 lotion Substances 0.000 description 14
- 239000000463 material Substances 0.000 description 14
- 241000588724 Escherichia coli Species 0.000 description 13
- 230000001580 bacterial effect Effects 0.000 description 12
- 239000000645 desinfectant Substances 0.000 description 12
- -1 phenol compound Chemical class 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 238000010899 nucleation Methods 0.000 description 11
- 238000005406 washing Methods 0.000 description 11
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 10
- 230000036541 health Effects 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 239000000344 soap Substances 0.000 description 10
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 9
- 241000191967 Staphylococcus aureus Species 0.000 description 9
- 238000013207 serial dilution Methods 0.000 description 9
- 229910052709 silver Inorganic materials 0.000 description 9
- 239000004332 silver Substances 0.000 description 9
- 238000009331 sowing Methods 0.000 description 9
- 238000001356 surgical procedure Methods 0.000 description 9
- 230000008901 benefit Effects 0.000 description 8
- 238000011084 recovery Methods 0.000 description 8
- 239000008199 coating composition Substances 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 229940068196 placebo Drugs 0.000 description 7
- 239000000902 placebo Substances 0.000 description 7
- 230000002335 preservative effect Effects 0.000 description 7
- 238000011012 sanitization Methods 0.000 description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 7
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- ZPLCXHWYPWVJDL-UHFFFAOYSA-N 4-[(4-hydroxyphenyl)methyl]-1,3-oxazolidin-2-one Chemical compound C1=CC(O)=CC=C1CC1NC(=O)OC1 ZPLCXHWYPWVJDL-UHFFFAOYSA-N 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 6
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000008272 agar Substances 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 239000000417 fungicide Substances 0.000 description 6
- 239000012633 leachable Substances 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 5
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 239000004743 Polypropylene Substances 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 230000002688 persistence Effects 0.000 description 5
- 229920001155 polypropylene Polymers 0.000 description 5
- 150000003856 quaternary ammonium compounds Chemical group 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 230000003385 bacteriostatic effect Effects 0.000 description 4
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical group ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- 125000005442 diisocyanate group Chemical group 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 241000194033 Enterococcus Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241000960592 Pseudomonas aeruginosa group Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000007334 copolymerization reaction Methods 0.000 description 3
- 239000011928 denatured alcohol Substances 0.000 description 3
- WSFMFXQNYPNYGG-UHFFFAOYSA-M dimethyl-octadecyl-(3-trimethoxysilylpropyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCC[Si](OC)(OC)OC WSFMFXQNYPNYGG-UHFFFAOYSA-M 0.000 description 3
- 239000006153 eosin methylene blue Substances 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000007769 metal material Substances 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 150000002978 peroxides Chemical class 0.000 description 3
- 239000006152 selective media Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 230000002459 sustained effect Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 238000009849 vacuum degassing Methods 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229920003176 water-insoluble polymer Polymers 0.000 description 3
- 229920003169 water-soluble polymer Polymers 0.000 description 3
- TVXNKQRAZONMHJ-UHFFFAOYSA-M (4-ethenylphenyl)methyl-trimethylazanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1=CC=C(C=C)C=C1 TVXNKQRAZONMHJ-UHFFFAOYSA-M 0.000 description 2
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 2
- DPBJAVGHACCNRL-UHFFFAOYSA-N 2-(dimethylamino)ethyl prop-2-enoate Chemical compound CN(C)CCOC(=O)C=C DPBJAVGHACCNRL-UHFFFAOYSA-N 0.000 description 2
- IUVCFHHAEHNCFT-INIZCTEOSA-N 2-[(1s)-1-[4-amino-3-(3-fluoro-4-propan-2-yloxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-fluoro-3-(3-fluorophenyl)chromen-4-one Chemical compound C1=C(F)C(OC(C)C)=CC=C1C(C1=C(N)N=CN=C11)=NN1[C@@H](C)C1=C(C=2C=C(F)C=CC=2)C(=O)C2=CC(F)=CC=C2O1 IUVCFHHAEHNCFT-INIZCTEOSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical class OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 229920002413 Polyhexanide Polymers 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 108010059993 Vancomycin Proteins 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 239000012300 argon atmosphere Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical group ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 2
- 229940073608 benzyl chloride Drugs 0.000 description 2
- 239000003139 biocide Substances 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000012531 culture fluid Substances 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000012953 feeding on blood of other organism Effects 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 230000000855 fungicidal effect Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000009036 growth inhibition Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 229940050176 methyl chloride Drugs 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 210000002445 nipple Anatomy 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- PFUVRDFDKPNGAV-UHFFFAOYSA-N sodium peroxide Chemical compound [Na+].[Na+].[O-][O-] PFUVRDFDKPNGAV-UHFFFAOYSA-N 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- RRHXZLALVWBDKH-UHFFFAOYSA-M trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium;chloride Chemical compound [Cl-].CC(=C)C(=O)OCC[N+](C)(C)C RRHXZLALVWBDKH-UHFFFAOYSA-M 0.000 description 2
- 229960003165 vancomycin Drugs 0.000 description 2
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 2
- MYPYJXKWCTUITO-LYRMYLQWSA-O vancomycin(1+) Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C([O-])=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)[NH2+]C)[C@H]1C[C@](C)([NH3+])[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-O 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- XMNIXWIUMCBBBL-UHFFFAOYSA-N 2-(2-phenylpropan-2-ylperoxy)propan-2-ylbenzene Chemical compound C=1C=CC=CC=1C(C)(C)OOC(C)(C)C1=CC=CC=C1 XMNIXWIUMCBBBL-UHFFFAOYSA-N 0.000 description 1
- CQVWXNBVRLKXPE-UHFFFAOYSA-N 2-octyl cyanoacrylate Chemical compound CCCCCCC(C)OC(=O)C(=C)C#N CQVWXNBVRLKXPE-UHFFFAOYSA-N 0.000 description 1
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical group C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000191070 Escherichia coli ATCC 8739 Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920002396 Polyurea Polymers 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241001494106 Stenotomus chrysops Species 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 239000005456 alcohol based solvent Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical class C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000009924 canning Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 229910001919 chlorite Inorganic materials 0.000 description 1
- 229910052619 chlorite group Inorganic materials 0.000 description 1
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical compound C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 1
- YIOJGTBNHQAVBO-UHFFFAOYSA-N dimethyl-bis(prop-2-enyl)azanium Chemical group C=CC[N+](C)(C)CC=C YIOJGTBNHQAVBO-UHFFFAOYSA-N 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000005414 inactive ingredient Substances 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical class CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000007870 radical polymerization initiator Substances 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 150000003378 silver Chemical class 0.000 description 1
- 229940100890 silver compound Drugs 0.000 description 1
- 150000003379 silver compounds Chemical class 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000007655 standard test method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 150000003440 styrenes Chemical class 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960005196 titanium dioxide Drugs 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
- A01N33/02—Amines; Quaternary ammonium compounds
- A01N33/12—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pest Control & Pesticides (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Agronomy & Crop Science (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71012805P | 2005-08-22 | 2005-08-22 | |
| US80619606P | 2006-06-29 | 2006-06-29 | |
| PCT/US2006/032954 WO2007024973A1 (en) | 2005-08-22 | 2006-08-22 | Disinfectant with quaternary ammonium polymers and copolymers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009506055A true JP2009506055A (ja) | 2009-02-12 |
| JP2009506055A5 JP2009506055A5 (https=) | 2011-01-13 |
Family
ID=37771939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008528125A Pending JP2009506055A (ja) | 2005-08-22 | 2006-08-22 | 第四級アンモニウムポリマーおよびコポリマーを用いた殺菌剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8088400B2 (https=) |
| EP (1) | EP1928234A4 (https=) |
| JP (1) | JP2009506055A (https=) |
| AU (1) | AU2006283042B2 (https=) |
| BR (1) | BRPI0617092A2 (https=) |
| CA (1) | CA2620175C (https=) |
| WO (1) | WO2007024973A1 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011511103A (ja) * | 2008-01-08 | 2011-04-07 | クイック−メッド テクノロジーズ、インク． | 殺菌性アルコール可溶性第四級アンモニウムポリマー |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8088400B2 (en) | 2005-08-22 | 2012-01-03 | Quick-Med Technologies, Inc. | Disinfectant with quarternary ammonium polymer and copolymers |
| US8343523B2 (en) | 2005-08-22 | 2013-01-01 | Quick-Med Technologies, Inc. | Disinfectant with durable activity based on alcohol-soluble quaternary ammonium polymers and copolymers |
| US8435500B2 (en) * | 2005-11-01 | 2013-05-07 | L'oréal | Nail whitening composition |
| US8450378B2 (en) | 2006-02-09 | 2013-05-28 | Gojo Industries, Inc. | Antiviral method |
| US9629361B2 (en) | 2006-02-09 | 2017-04-25 | Gojo Industries, Inc. | Composition and method for pre-surgical skin disinfection |
| US8119115B2 (en) | 2006-02-09 | 2012-02-21 | Gojo Industries, Inc. | Antiviral method |
| AT505312A1 (de) * | 2007-05-15 | 2008-12-15 | Recticel Schlafkomfort Gmbh Sc | Polyurethan-werkstoff mit einer bioziden ausrüstung |
| CN101611716A (zh) * | 2009-07-31 | 2009-12-30 | 上海创联生物科技有限公司 | 一种组合型季铵盐高效杀菌消毒剂 |
| WO2012080918A2 (en) | 2010-12-14 | 2012-06-21 | Ecolab Usa Inc. | Wear resistant antimicrobial compositions and methods of use |
| RU2445980C1 (ru) * | 2010-12-30 | 2012-03-27 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет тонких химических технологий имени М.В.Ломоносова" (МИТХТ) | Способ изготовления полимерного комплекса, обладающего антисептическими свойствами, и антисептического покрытия на его основе |
| US8815996B2 (en) * | 2011-06-01 | 2014-08-26 | The United States Of America As Represented By The Secretary Of The Army | Surface segregating additives for enhanced chemical agent resistant topcoats |
| FR2976486B1 (fr) * | 2011-06-20 | 2013-10-11 | Oreal | Utilisation comme agent anti-transpirant d'un polymere polyurethane cationique floculant |
| EP2958964A4 (en) * | 2013-02-21 | 2016-08-10 | Cleanspot Inc | TREATMENT OF FREQUENTLY AFFECTED SURFACES TO IMPROVE HYGIENE |
| WO2014138821A1 (en) * | 2013-03-15 | 2014-09-18 | Air Sanz Holdings Pty Ltd | Improved air purifying apparatus, method & use of chemical substance |
| RU2535087C1 (ru) * | 2013-07-11 | 2014-12-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет тонких химических технологий имени М.В. Ломоносова" (МИТХТ им. М.В. Ломоносова) | Способ изготовления полимерного комплекса, обладающего антисептическими свойствами, и антисептического покрытия на его основе |
| US9145536B2 (en) * | 2013-12-20 | 2015-09-29 | Church & Dwight Co., Inc. | Peroxide-containing cleaning composition with enhanced peroxide stability |
| BR112019001440A2 (pt) | 2016-07-28 | 2019-04-30 | eXion labs Inc. | composições antimicrobianas e métodos para matar micróbios em uma superfície |
| CN111032060A (zh) * | 2017-06-28 | 2020-04-17 | 科利迪恩公司 | 用于清洁、消毒和/或灭菌的组合物、方法和用途 |
| SG11202006664UA (en) | 2018-01-14 | 2020-08-28 | Collidion Inc | Compositions, kits, methods and uses for cleaning, disinfecting, sterilizing and/or treating |
| US12050227B2 (en) | 2018-04-17 | 2024-07-30 | Nara Institute Of Science And Technology | Lipid nanodisc formation by acryloyl-based copolymers |
| US12245591B2 (en) | 2019-02-05 | 2025-03-11 | The Board Of Trustees Of The University Of Arkansas | Templated antimicrobial microgels and methods of making and using the same |
| US11813358B2 (en) | 2019-06-07 | 2023-11-14 | Regents Of The University Of Michigan | Lipid nanodisc formation by polymers having a pendant hydrophobic group |
| US11590064B2 (en) * | 2019-10-04 | 2023-02-28 | Johnson & Johnson Consumer Inc. | Sprayable sunscreen composition |
| CA3167941A1 (en) | 2020-02-14 | 2021-08-19 | Collidion, Inc. | Compositions, kits, methods and uses for cleaning, disinfecting, sterilizing and/or treating |
| KR20250073671A (ko) * | 2022-09-28 | 2025-05-27 | 폴라로이드 아이피 비.브이. | 항균 코팅 조성물 |
Citations (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0592129A (ja) * | 1991-09-30 | 1993-04-16 | Nitto Denko Corp | 複合半透膜 |
| JPH11147927A (ja) * | 1997-11-17 | 1999-06-02 | Inoac Corporation:Kk | 抗菌性ポリウレタン樹脂及びその製造方法 |
| JPH11269448A (ja) * | 1997-12-22 | 1999-10-05 | Sanyo Chem Ind Ltd | 抗菌性を有する感圧接着剤 |
| JP2000273017A (ja) * | 1999-03-24 | 2000-10-03 | Kao Corp | 角栓除去剤 |
| JP2001517632A (ja) * | 1997-09-19 | 2001-10-09 | ジェルテックス ファーマシューティカルズ，インコーポレイテッド | 毒素結合剤としてのカチオン性ポリマー |
| JP2002515039A (ja) * | 1996-06-24 | 2002-05-21 | ジェルテックス ファーマシューティカルズ，インコーポレイテッド | 抗感染剤としてのイオン性ポリマー |
| JP2002172850A (ja) * | 2000-12-07 | 2002-06-18 | Konica Corp | インクジェット記録用紙 |
| JP2002348338A (ja) * | 1992-11-04 | 2002-12-04 | Alcon Lab Inc | 新規の重合体抗菌剤類及び薬剤組成物へのそれらの使用 |
| JP2002544226A (ja) * | 1999-05-13 | 2002-12-24 | ジェルテックス ファーマシューティカルズ，インコーポレイテッド | 毒素結合剤としてのアニオン性ポリマーおよび抗菌剤 |
| JP2002544348A (ja) * | 1999-05-12 | 2002-12-24 | クレアヴィス ゲゼルシャフト フュア テヒノロギー ウント イノヴェイション ミット ベシュレンクテル ハフツング | 抗微生物性コポリマー |
| JP2005515235A (ja) * | 2002-01-16 | 2005-05-26 | スリーエム イノベイティブ プロパティズ カンパニー | 消毒用組成物および方法 |
| WO2005074947A2 (en) * | 2003-12-10 | 2005-08-18 | Sd Pharmaceuticals, Inc. | Anti-viral pharmaceutical compositions |
| US20050184273A1 (en) * | 2001-05-16 | 2005-08-25 | Ecolab Inc. | Acidified chlorite disinfectant compositions with olefin stabilizers |
| WO2005110485A1 (en) * | 2004-05-14 | 2005-11-24 | Interface Biologics Inc. | Polymeric coupling agents and pharmaceutically-active polymers made therefrom |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4110286A (en) * | 1977-02-07 | 1978-08-29 | Alcolac Inc. | Stable polyurethane latices, emulsifiable prepolymers therefor and methods of making the same |
| US4723950A (en) * | 1984-12-12 | 1988-02-09 | C. R. Bard, Inc. | Urine drainage bag outlet with barrier against microbial infection |
| US4789720A (en) * | 1988-03-09 | 1988-12-06 | Tyndale Plains-Hunter, Ltd. | Hydrophilic polyurethanes prepared from mixed oxyalkylene glycols |
| CA1316623C (en) * | 1989-04-06 | 1993-04-20 | Pavel Stovicek | Biocidal surface coating and casting compositions based on quarternary ammonium salts of nalkyl x,x bis (4,4' hydroxyphenyl) and quarternary salts of polyglycols as backbones of resins |
| US5399343A (en) * | 1990-05-30 | 1995-03-21 | Dr. W. Novis Smith And Company, Inc. | Biocidal cosmetic compositions |
| GB9406854D0 (en) * | 1994-04-07 | 1994-06-01 | Gillette Co | Antiperspirants |
| US6017561A (en) * | 1997-04-04 | 2000-01-25 | The Clorox Company | Antimicrobial cleaning composition |
| US7709694B2 (en) * | 1998-12-08 | 2010-05-04 | Quick-Med Technologies, Inc. | Materials with covalently-bonded, nonleachable, polymeric antimicrobial surfaces |
| US6605666B1 (en) * | 2000-07-27 | 2003-08-12 | 3M Innovative Properties Company | Polyurethane film-forming dispersions in alcohol-water system |
| US7151139B2 (en) * | 2001-04-23 | 2006-12-19 | Massachusetts Institute Of Technology | Antimicrobial polymeric surfaces |
| US6838078B2 (en) * | 2002-01-16 | 2005-01-04 | 3M Innovative Properties Company | Film-forming compositions and methods |
| US9028852B2 (en) * | 2004-09-07 | 2015-05-12 | 3M Innovative Properties Company | Cationic antiseptic compositions and methods of use |
| DE102005002644A1 (de) | 2005-01-19 | 2006-07-20 | Schülke & Mayr GmbH | Zusammensetzungen für die hygienische Händedesinfektion und die desinfizierende Händewaschung |
| GB0505634D0 (en) * | 2005-03-18 | 2005-04-27 | Guy Allen Ltd | Antimicrobial composition |
| US8088400B2 (en) | 2005-08-22 | 2012-01-03 | Quick-Med Technologies, Inc. | Disinfectant with quarternary ammonium polymer and copolymers |
-
2006
- 2006-08-22 US US12/064,487 patent/US8088400B2/en not_active Expired - Fee Related
- 2006-08-22 JP JP2008528125A patent/JP2009506055A/ja active Pending
- 2006-08-22 WO PCT/US2006/032954 patent/WO2007024973A1/en not_active Ceased
- 2006-08-22 BR BRPI0617092-7A patent/BRPI0617092A2/pt not_active IP Right Cessation
- 2006-08-22 EP EP06813679A patent/EP1928234A4/en not_active Withdrawn
- 2006-08-22 AU AU2006283042A patent/AU2006283042B2/en not_active Ceased
- 2006-08-22 CA CA2620175A patent/CA2620175C/en not_active Expired - Fee Related
-
2011
- 2011-12-30 US US13/341,470 patent/US20120141396A1/en not_active Abandoned
Patent Citations (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0592129A (ja) * | 1991-09-30 | 1993-04-16 | Nitto Denko Corp | 複合半透膜 |
| JP2002348338A (ja) * | 1992-11-04 | 2002-12-04 | Alcon Lab Inc | 新規の重合体抗菌剤類及び薬剤組成物へのそれらの使用 |
| JP2002515039A (ja) * | 1996-06-24 | 2002-05-21 | ジェルテックス ファーマシューティカルズ，インコーポレイテッド | 抗感染剤としてのイオン性ポリマー |
| JP2001517632A (ja) * | 1997-09-19 | 2001-10-09 | ジェルテックス ファーマシューティカルズ，インコーポレイテッド | 毒素結合剤としてのカチオン性ポリマー |
| JPH11147927A (ja) * | 1997-11-17 | 1999-06-02 | Inoac Corporation:Kk | 抗菌性ポリウレタン樹脂及びその製造方法 |
| JPH11269448A (ja) * | 1997-12-22 | 1999-10-05 | Sanyo Chem Ind Ltd | 抗菌性を有する感圧接着剤 |
| JP2000273017A (ja) * | 1999-03-24 | 2000-10-03 | Kao Corp | 角栓除去剤 |
| JP2002544348A (ja) * | 1999-05-12 | 2002-12-24 | クレアヴィス ゲゼルシャフト フュア テヒノロギー ウント イノヴェイション ミット ベシュレンクテル ハフツング | 抗微生物性コポリマー |
| JP2002544226A (ja) * | 1999-05-13 | 2002-12-24 | ジェルテックス ファーマシューティカルズ，インコーポレイテッド | 毒素結合剤としてのアニオン性ポリマーおよび抗菌剤 |
| JP2002172850A (ja) * | 2000-12-07 | 2002-06-18 | Konica Corp | インクジェット記録用紙 |
| US20050184273A1 (en) * | 2001-05-16 | 2005-08-25 | Ecolab Inc. | Acidified chlorite disinfectant compositions with olefin stabilizers |
| JP2005515235A (ja) * | 2002-01-16 | 2005-05-26 | スリーエム イノベイティブ プロパティズ カンパニー | 消毒用組成物および方法 |
| WO2005074947A2 (en) * | 2003-12-10 | 2005-08-18 | Sd Pharmaceuticals, Inc. | Anti-viral pharmaceutical compositions |
| WO2005110485A1 (en) * | 2004-05-14 | 2005-11-24 | Interface Biologics Inc. | Polymeric coupling agents and pharmaceutically-active polymers made therefrom |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011511103A (ja) * | 2008-01-08 | 2011-04-07 | クイック−メッド テクノロジーズ、インク． | 殺菌性アルコール可溶性第四級アンモニウムポリマー |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007024973A1 (en) | 2007-03-01 |
| EP1928234A4 (en) | 2012-08-29 |
| CA2620175A1 (en) | 2007-03-01 |
| US8088400B2 (en) | 2012-01-03 |
| CA2620175C (en) | 2013-04-30 |
| AU2006283042A1 (en) | 2007-03-01 |
| US20120141396A1 (en) | 2012-06-07 |
| BRPI0617092A2 (pt) | 2011-07-12 |
| US20090246165A1 (en) | 2009-10-01 |
| EP1928234A1 (en) | 2008-06-11 |
| AU2006283042B2 (en) | 2012-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8343523B2 (en) | Disinfectant with durable activity based on alcohol-soluble quaternary ammonium polymers and copolymers | |
| AU2009204189B2 (en) | Disinfectant alcohol-soluble quaternary ammonium polymers | |
| JP2009506055A (ja) | 第四級アンモニウムポリマーおよびコポリマーを用いた殺菌剤 | |
| EP1111995B1 (en) | Topical dermal antimicrobial compositions | |
| AU2008347253B2 (en) | Antimicrobial compositions | |
| US20030147925A1 (en) | Topical dermal antimicrobial compositions, methods for generating same, and monitoring methods utilizing same | |
| JP2005531637A (ja) | 消毒組成物 | |
| JP2009523890A (ja) | 微生物付着防止用の非浸出性表面活性フィルム組成物 | |
| Arora et al. | Polymer based antimicrobial coatings as potential biomaterial: A review | |
| Floros et al. | Antimicrobial activity of amphiphilic triazole-linked polymers derived from renewable sources | |
| JP2013515048A (ja) | 細菌を固定化する皮膚前処理剤 | |
| CN101291580B (zh) | 季铵聚合物和共聚物的消毒剂 | |
| Yuan et al. | Synergistic sporicidal effect of ethanol on a combination of orthophthalaldehyde and Didecyldimethylammonium chloride | |
| MX2008002346A (en) | Disinfectant with quaternary ammonium polymers and copolymers | |
| Nishioka et al. | Pharmaceutical properties of a tinted formulation of a biguanide antiseptic agent, olanexidine gluconate | |
| Paulson | Topical antimicrobials: classification and performance | |
| ROTTER | Alcohols for Antisepsis of Hands | |
| Paulson | Antimicrobials: Topical Performance | |
| AU2012358311A1 (en) | Non-corrosive stable peracetic acid concentrate solution |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090822 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101015 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101111 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101117 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120522 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120814 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120821 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121122 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20121122 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130625 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140225 |